Telomir Pharmaceuticals
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
900 W Platt St, Tampa, Florida, 33606, U...Phone Number
(813) 864-2558Website
www.telomirpharma.comRevenue
<$5 MillionStock Symbol
TELOIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Telomir Pharmaceuticals
Telomir 1 is under investigation to potentially provide a therapeutic intervention against age-related inflammatory conditions. It is being developed to protect stem cells by elongating and stimulating the telomeres to sustain self-renewalExplore more
Telomir Pharmaceuticals Org Chart
AM
Fractional Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Telomir Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Telomir Pharmaceuticals launches new products
Check if Telomir Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Telomir Pharmaceuticals has new funding data
Check out if Telomir Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Telomir Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Telomir Pharmaceuticals
Earning: See what the market has to say on Telomir Pharmaceuticals recently announced quarterly report
Telomir Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Telomir Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Telomir Pharmaceuticals
Compare insights from companies similar to Telomir Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Telomir Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Telomir Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Telomir Pharmaceuticals.
Telomir Pharmaceuticals financials insights
Gather financial insights about Telomir Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Multiple Rounds
$13M
2025
Other Financing Round
$3M
Telomir Pharmaceuticals Tech Stack
A closer look at the technologies used by Telomir Pharmaceuticals
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Funding
Funding
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Telomir Pharmaceuticals News & Media
TELO Rises on Promising Telomir-1 Preclinical Results
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) is among the 10 Best Growth Stocks Under $100 to Buy Now. On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) revealed that its leading product, Telomir-1, showcased a marked improvement in the neurological, liver, and kidney symptoms observed in a preclinical animal model of Wilson’s disease. In a zebrafish model mimicking Wilson’s disease, […]Telomir Pharmaceuticals Appoints New Chief Financial Officer - TipRanks.com
The latest update is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). On May 16, 2025, Telomir Pharmaceuticals, Inc. announced the mutual resignation of Michelle...Telomir Pharmaceuticals Secures $3M Equity Financing Boost - TipRanks.com
Telomir Pharmaceuticals, Inc. ( ($TELO) ) has provided an announcement. On May 19, 2025, Telomir Pharmaceuticals secured $3 million in equity financing through a di...EXCLUSIVE: Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND
On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) announced that it had secured $3 million in equity financing through a direct investment by The Bayshore Trust, the company's largest shareholder. The transaction involved the purchase of 1 million restricted shares of the company's common stock at $3.00 per share, representing an 18% premium to Telomir's closing share price of $2.54 on the execution date. The transaction was structured as a straight restricted common stock transaction. A
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Telomir Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Telomir 1 is under investigation to potentially provide a therapeutic intervention against age-related inflammatory conditions. It is being developed to protect stem cells by elongating and stimulating the telomeres to sustain self-renewal... Read More
